Charmi Patel, MD
Allergy & Immunology · Watkinsville, GANPI 1831432863
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,093, more than ten times the $67 reported in 2019.
Across 244 payments — averaging $22.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$793
- Alk-abello, Inc$695
- GSK$617
- Takeda Pharmaceuticals U.S.A., Inc.$610
- Sanofi$456
- CSL Behring$447
- plus $2K from 22 others
What the payments were for
- Consulting fees$260%
- Speaking & faculty fees$250%
- Food & beverage$5,51599%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 31 | $793 |
| Alk-abello, Inc | 12 | $695 |
| GSK | 41 | $617 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $610 |
| Sanofi | 16 | $456 |
| CSL Behring | 22 | $447 |
| Grifols USA, LLC | 12 | $247 |
| Optinose US, Inc. | 11 | $185 |
| Amgen | 9 | $184 |
| Biocryst US Sales Co., LLC | 8 | $169 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $160 |
| Pfizer | 6 | $139 |
| Novartis | 6 | $120 |
| Regeneron Healthcare Solutions, Inc. | 4 | $106 |
| Kaleo, Inc. | 5 | $88 |
| Genentech USA, Inc. | 5 | $86 |
| Cycle Pharmaceuticals Inc | 3 | $68 |
| Hikma Pharmaceuticals USA | 3 | $56 |
| Incyte Corporation | 3 | $53 |
| Organon | 2 | $51 |
| Galderma Laboratories, L.p. | 3 | $45 |
| Pharming Healthcare, Inc. | 2 | $38 |
| Phadia US Inc. | 2 | $37 |
| LEO Pharma Inc. | 2 | $36 |
| ADMA Biomanufacturing LLC | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| X4 Pharmaceuticals, Inc. | 1 | $22 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
How this compares
$5,579 in reported general payments places this provider in the 55th percentile of 107 allergy & immunology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 30 | $537 |
| Fluticasone Propionate | 11 | $87 |
| Famotidine | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Watkinsville
- Michael BlaissRoswell$1.1M
- Deborah BirxAtlanta$470K
- Tracy BridgesAlbany$364K
- Jack EadesMacon$237K
- Stanley FinemanMarietta$186K
- Robert CartwrightColumbus$169K
- Robert ChrzanowskiColumbus$115K
- Belinda GrahamSmyrna$94K
- Lily HwangRoswell$88K
- Paul RabinowitzAtlanta$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.